It is a pharma private limited company based in Shahdara, Delhi, India, established in 2019.
2019 | Shahdara, Delhi, India | ActiveGlenford Pharmaceuticals Private Limited, a active private limited company, was established on 18 November 2019 in Shahdara, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909DL2019PTC357636. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Mohit Saini (Director), Munish Kumar Jain (Additional Director). Past directors included Munish Kumar Jain, Mohit Saini, Beenu Jain. It holds ₹7.70 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1/6464,2Nd Floor East Rohtash Nagar, Shahdara, Delhi, 110032.
U51909DL2019PTC357636
357636
18 November 2019
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Glenford Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mohit Saini | Director | 02 Mar 2021 | Current |
| Munish Kumar Jain | Additional Director | 17 Nov 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Oct 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Glenford Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 49.94% increase. The company also saw a substantial improvement in profitability, with a 16.58% increase in profit. The company's net worth Soared by an impressive increase of 113.3%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Glenford Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹7,700,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Jan 2024 | Hdfc Bank Limited | ₹7.70 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Glenford Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Glenford Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glenford Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Munish Kumar Jain was appointed as a Additional Director was appointed as a Additional Director on 17 Nov 2025 & has been associated with this company since 1 month 5 days . was completed.
The activity Glenford Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Glenford Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
The activity A charge with Hdfc Bank Limited amounted to Rs. 7.70 M with Charge ID 100855530 was registered on 01 Jan 2024. was completed.
Mohit Saini was appointed as a Director was appointed as a Director on 02 Mar 2021 & has been associated with this company since 4 years 9 months . was recorded as a recent event.
Glenford Pharmaceuticals Private Limited was registered on 18 Nov 2019 with Roc Delhi & aged 6 years 1 month as per MCA records. was recorded as a recent event.
The CIN of Glenford Pharmaceuticals Private Limited is U51909DL2019PTC357636.
Glenford Pharmaceuticals Private Limited is headquartered at 1/6464,2Nd Floor East Rohtash Nagar, Shahdara, Delhi, 110032.
Glenford Pharmaceuticals Private Limited was incorporated on 18 November 2019.
The current directors of Glenford Pharmaceuticals Private Limited are
The primary industry of Glenford Pharmaceuticals Private Limited is Trade.
Glenford Pharmaceuticals Private Limited is unlisted.
The authorized capital of Glenford Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX